Arvee Laboratories (India) Limited Net Assets
Arvee Laboratories (India) Limited net assets. Based on the latest financial reports, Arvee Laboratories (India) Limited (ARVEE) has net assets worth Rs314.41 Million INR (≈ $3.40 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs405.81 Million ≈ $4.39 Million USD) and total liabilities (Rs91.40 Million ≈ $988.48K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset growth rate of Arvee Laboratories (India) Limited to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs314.41 Million |
| % of Total Assets | 77.48% |
| Annual Growth Rate | 62.38% |
| 5-Year Change | 45.82% |
| 10-Year Change | 1083.74% |
| Growth Volatility | 874.57 |
Net Assets of Arvee Laboratories (India) Limited (2013–2025)
Net assets of Arvee Laboratories (India) Limited from 2013 to 2025. This chart illustrates how Arvee Laboratories (India) Limited's net assets have evolved over time, based on quarterly financial data. See ARVEE net asset quality score to measure how much of total assets are equity-financed.
Annual Net Assets for Arvee Laboratories (India) Limited (2013–2025)
The table below shows the annual net assets of Arvee Laboratories (India) Limited from 2013 to 2025. For live market cap and overall valuation, see Arvee Laboratories (India) Limited stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs312.61 Million ≈ $3.38 Million |
+7.38% |
| 2024-03-31 | Rs291.14 Million ≈ $3.15 Million |
+3.75% |
| 2023-03-31 | Rs280.62 Million ≈ $3.03 Million |
+17.21% |
| 2022-03-31 | Rs239.42 Million ≈ $2.59 Million |
+11.68% |
| 2021-03-31 | Rs214.38 Million ≈ $2.32 Million |
+14.71% |
| 2020-03-31 | Rs186.89 Million ≈ $2.02 Million |
+13.53% |
| 2019-03-31 | Rs164.62 Million ≈ $1.78 Million |
+15.94% |
| 2018-03-31 | Rs141.99 Million ≈ $1.54 Million |
+238.56% |
| 2017-03-31 | Rs41.94 Million ≈ $453.55K |
+58.81% |
| 2016-03-31 | Rs26.41 Million ≈ $285.60K |
+86.66% |
| 2015-03-31 | Rs14.15 Million ≈ $153.01K |
-53.79% |
| 2014-03-31 | Rs30.62 Million ≈ $331.12K |
+3192.26% |
| 2013-03-31 | Rs930.00K ≈ $10.06K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Arvee Laboratories (India) Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 42470.5% over the analyzed period, indicating profitable operations and earnings retention.
Arvee Laboratories (India) Limited Net Assets Breakdown (March 2025)
Arvee Laboratories (India) Limited net assets breakdown by equity component as of March 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs183.05 Million | 58.56% |
| Common Stock | Rs110.20 Million | 35.25% |
| Other Components | Rs19.36 Million | 6.19% |
| Total Equity | Rs312.61 Million | 100.00% |
Arvee Laboratories (India) Limited Competitors by Market Cap
The table below lists competitors of Arvee Laboratories (India) Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Galil Capital Re Spain SOCIMI SA
MC:YGCS
|
$25.75 Million |
|
Lachish
TA:LHIS
|
$25.75 Million |
|
Terranet AB
ST:TERRNT-B
|
$25.76 Million |
|
MST GOLF GROUP BERHAD
KLSE:5316
|
$25.76 Million |
|
DocGo Inc
NASDAQ:DCGO
|
$25.74 Million |
|
BG T&A Co
KQ:046310
|
$25.74 Million |
|
Kincora Copper Ltd
AU:KCC
|
$25.71 Million |
|
Alara Resources Ltd
AU:AUQ
|
$25.70 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Arvee Laboratories (India) Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 291,140,220 to 312,613,000, a change of 21,472,780 (7.4%).
- Net income of 21,474,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 180,940,000.
- Other factors increased equity by 180,938,780.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs21.47 Million | +6.87% |
| Other Comprehensive Income | Rs-180.94 Million | -57.88% |
| Other Changes | Rs180.94 Million | +57.88% |
| Total Change | Rs- | 7.38% |
Book Value vs Market Value Analysis
This analysis compares Arvee Laboratories (India) Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.64x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 2559.84x to 7.64x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-03-31 | Rs0.08 | Rs216.03 | x |
| 2014-03-31 | Rs2.78 | Rs216.03 | x |
| 2015-03-31 | Rs1.28 | Rs216.03 | x |
| 2016-03-31 | Rs2.40 | Rs216.03 | x |
| 2017-03-31 | Rs3.81 | Rs216.03 | x |
| 2018-03-31 | Rs16.85 | Rs216.03 | x |
| 2019-03-31 | Rs14.94 | Rs216.03 | x |
| 2020-03-31 | Rs16.96 | Rs216.03 | x |
| 2021-03-31 | Rs19.45 | Rs216.03 | x |
| 2022-03-31 | Rs21.73 | Rs216.03 | x |
| 2023-03-31 | Rs25.46 | Rs216.03 | x |
| 2024-03-31 | Rs26.42 | Rs216.03 | x |
| 2025-03-31 | Rs28.27 | Rs216.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Arvee Laboratories (India) Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.87%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.58%
- • Asset Turnover: 1.01x
- • Equity Multiplier: 1.22x
- Recent ROE (6.87%) is above the historical average (4.36%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 46.24% | 1.25% | 0.39x | 95.78x | Rs337.00K |
| 2014 | 0.61% | 0.16% | 0.68x | 5.69x | Rs-2.87 Million |
| 2015 | -116.41% | -12.70% | 0.50x | 18.40x | Rs-17.88 Million |
| 2016 | 7.10% | 0.70% | 0.76x | 13.33x | Rs-766.90K |
| 2017 | 37.00% | 4.51% | 0.96x | 8.51x | Rs11.32 Million |
| 2018 | 7.67% | 2.43% | 1.01x | 3.11x | Rs-3.31 Million |
| 2019 | 13.75% | 4.19% | 1.45x | 2.26x | Rs6.17 Million |
| 2020 | 12.30% | 5.13% | 1.33x | 1.80x | Rs4.30 Million |
| 2021 | 12.49% | 5.68% | 1.15x | 1.91x | Rs5.34 Million |
| 2022 | 10.75% | 6.38% | 1.04x | 1.62x | Rs1.80 Million |
| 2023 | 14.68% | 6.72% | 1.58x | 1.38x | Rs13.13 Million |
| 2024 | 3.61% | 3.47% | 0.79x | 1.31x | Rs-18.60 Million |
| 2025 | 6.87% | 5.58% | 1.01x | 1.22x | Rs-9.79 Million |
Industry Comparison
This section compares Arvee Laboratories (India) Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $9,366,933,870
- Average return on equity (ROE) among peers: 13.66%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Arvee Laboratories (India) Limited (ARVEE) | Rs314.41 Million | 46.24% | 0.29x | $25.75 Million |
| Aarti Industries Limited (AARTIIND) | $16.55 Billion | 20.11% | 1.65x | $1.75 Billion |
| Aarti Surfactants Limited (AARTISURF) | $1.33 Billion | 16.31% | 1.89x | $43.63 Million |
| ABM International Limited (ABMINTLLTD) | $127.92 Million | -37.56% | 1.23x | $4.66 Million |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $645.35 Million | 25.83% | 1.39x | $333.56 Million |
| Aether Industries Limited (AETHER) | $24.56 Billion | 8.94% | 0.30x | $2.21 Billion |
| Akzo Nobel India Limited (AKZOINDIA) | $8.71 Billion | 53.16% | 0.51x | $1.60 Billion |
| Alkali Metals Limited (ALKALI) | $513.80 Million | 2.54% | 0.73x | $8.81 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $15.33 Billion | 11.74% | 0.24x | $879.16 Million |
| Ami Organics Limited (AMIORG) | $822.19 Million | 28.33% | 1.59x | $1.18 Billion |
| Anupam Rasayan India Limited (ANURAS) | $25.08 Billion | 7.21% | 0.51x | $1.41 Billion |
About Arvee Laboratories (India) Limited
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroi… Read more